Pharmaceutical Technology on MSN
FDA halts uniQure’s plans for Huntington’s disease gene therapy
"FDA halts uniQure’s plans for Huntington’s disease gene therapy" was originally created and published by Pharmaceutical ...
Hosted on MSN
A Huntington’s Disease Treatment Is Closer Than Ever
Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...
PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington’s disease (HD) patients. Huntington’s disease is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback